Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: High-frequency transcranial magnetic stimulation (TMS) interventions were approved for migraine headache by the US Food and Drug Administration since 2013; however, it is unclear if 10 Hz frequency repetitive TMS (rTMS) patient relapses, should frequency of TMS be enhanced to 20 Hz protocol? This case series addresses the effectiveness of 20 Hz frequency rTMS in treatment-refractory migraine patients.

Case Report: Five voluntary treatment-refractory migraine patients, referred from Medicine, Neurology, and Neurosurgery departments with mean duration of 11.8 years of migraine, not responding to any medications and failed to respond to 10 Hz frequency standard international guidelines, were subjected to 20 Hz, 5 sessions in the first week followed by weekly sessions for additional 4 weeks.

Conclusions: Compared to initial 10 Hz treatment, 20 Hz rTMS significantly reduced both frequency and severity of migraine. Over a follow-up period of 3-6 months, patients exhibited lasting improvements, indicating that 20 Hz rTMS is an effective neuromodulation intervention for individuals with refractory migraines.

Download full-text PDF

Source

Publication Analysis

Top Keywords

transcranial magnetic
12
magnetic stimulation
12
repetitive transcranial
8
case series
8
treatment-refractory migraine
8
migraine
6
frequency
5
high-frequency repetitive
4
stimulation case
4
series evaluating
4

Similar Publications

Postoperative aphasia (POA) is a common complication in patients undergoing surgery for language-eloquent lesions. This study aimed to enhance the prediction of POA by leveraging preoperative navigated transcranial magnetic stimulation (nTMS) language mapping and diffusion tensor imaging (DTI)-based tractography, incorporating deep learning (DL) algorithms. One hundred patients with left-hemispheric lesions were retrospectively enrolled (43 developed postoperative aphasia, as the POA group; 57 did not, as the non-aphasia (NA) group).

View Article and Find Full Text PDF

[Impact of transcranial magnetic stimulation on depressive symptoms relief in patients with chronic neuropathic pain and comorbid depression: A narrative literature review].

Encephale

September 2025

Centre de référence régional des pathologies anxieuses et de la dépression, pôle de psychiatrie générale et universitaire, centre hospitalier Charles-Perrens, 33076 Bordeaux, France; Inserm U1215, Neurocentre Magendie, 33000 Bordeaux, France. Electronic address:

Neuropathic pain results from an injury or a dysfunction of the somatosensory system. Management of this disease is complex due to a restricted therapeutic arsenal and limited efficacy of currently available treatments. Because of its chronic and disabling nature, neuropathic pain is strongly associated with depressive disorders.

View Article and Find Full Text PDF

The current study sought to explore the impact of a novel noninvasive treatment called transcranial photobiomodulation (PBM) on resting-state functional connectivity (rsFC) of the cerebellum in individuals with a history of repetitive head acceleration events (RHAEs). RHAEs are associated with cumulative neurological compromise, including chronic alterations in rsFC; however, few treatments have been investigated to mitigate these effects. A recent study by our team demonstrated that PBM treatment led to improvements in measures of balance and motor function in adults with RHAE exposure.

View Article and Find Full Text PDF

Introduction: Although emerging evidence supports the short-term efficacy of transcranial magnetic stimulation (TMS), including repetitive TMS (rTMS) and theta-burst transcranial magnetic stimulation (TBS-TMS), and transcranial direct current stimulation (tDCS) for managing patients with chronic musculoskeletal pain (CMP), their clinical utility in managing CMP remains inconclusive. This uncertainty may arise from methodological limitations, including heterogeneity in treatment parameters such as stimulation targets and dosages. Additionally, safety profiles for these non-invasive brain stimulation interventions in patients with CMP remain insufficiently reported, with limited data on adverse events, cumulative risks and long-term safety outcomes.

View Article and Find Full Text PDF

Biophysically Constrained Dynamical Modelling of the Brain Using Multimodal Magnetic Resonance Imaging.

Brain Res Bull

September 2025

Department of Psychiatry, Keck School of Medicine, University of Southern California, Los Angeles, CA; Institute for the Developing Mind, Children's Hospital Los Angeles, Los Angeles, CA.

We propose a Biophysically Restrained Analog Integrated Neural Network (BRAINN), an analog electrical network that models the dynamics of brain function. The network interconnects analog electrical circuits that simulate two tightly coupled brain processes: (1) propagation of an action potential, and (2) regional cerebral blood flow in response to the metabolic demands of signal propagation. These two processes are modeled by two branches of an electrical circuit comprising a resistor, a capacitor, and an inductor.

View Article and Find Full Text PDF